person · Reporting owner
Balachandran Madhavan
Disclosed activity across 5 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMGEN INCAMGN · Entity 2832 | EVP, Operations | May 03, 2016 | May 06, 2016 |
| Catalent, Inc.CTLT · Entity 16279 | Director | October 27, 2023 | October 31, 2023 |
| Replimune Group, Inc.REPL · Entity 4707 | Director | April 01, 2026 | April 08, 2026 |
| Stevanato Group S.p.A.STVN · Entity 3826 | Director | June 12, 2026 | June 26, 2026 |
| uniQure N.V.QURE · Entity 4162 | Director | June 17, 2026 | June 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMGEN INC
Report date May 03, 2016 · Filed May 06, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Family Trust | 55,996 |
Reported balance
After 2016-05-04 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2016-05-04 · Sale · Disposed 30,000 · Balance 55,996 F1: The price reported is an average price. The prices ranged from $153.53 to $154.54 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC, the issuer or a security holder of the issuer. |
| Common StockSEC Table I · non-derivative | Direct | 23,097 |
Reported balance
After 2016-05-03 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2016-05-03 · Grant · Acquired 3,581 · Balance 23,097 F2: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three installments of 33%, 33% and 34% on 5/3/2018, 5/3/2019 and 5/3/2020, respectively. F3: These shares include the following RSUs granted under the Company's equity plans: 9,056 RSUs which vest in one installment on 7/31/2016; 2,543 RSUs which vest on 1/28/2017; 3,154 RSUs which vest in one installment of 1,553 on 1/31/2017 and one installment of 1,601 on 1/31/2018; 3,677 RSUs which vest in two equal installments of 1,213 on 1/30/2017 and 1/30/2018 and one installment of 1,251 on 1/30/2019; and 3,581 RSUs which vest in installments of 1,181 on 5/3/2018, 1,182 on 5/3/2019 and 1,218 on 5/3/2020. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F4: These shares include 1,086 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. |
| Nqso (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $156.35 · Expires 2026-05-03 | Direct | 30,490 |
Reported balance
After 2016-05-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2016-05-03 · Grant · Acquired 30,490 · Balance 30,490 F5: These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/3/2018, 5/3/2019 and 5/3/2020, respectively. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported is an average price. The prices ranged from $153.53 to $154.54 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC, the issuer or a security holder of the issuer.
F2: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three installments of 33%, 33% and 34% on 5/3/2018, 5/3/2019 and 5/3/2020, respectively.
F3: These shares include the following RSUs granted under the Company's equity plans: 9,056 RSUs which vest in one installment on 7/31/2016; 2,543 RSUs which vest on 1/28/2017; 3,154 RSUs which vest in one installment of 1,553 on 1/31/2017 and one installment of 1,601 on 1/31/2018; 3,677 RSUs which vest in two equal installments of 1,213 on 1/30/2017 and 1/30/2018 and one installment of 1,251 on 1/30/2019; and 3,581 RSUs which vest in installments of 1,181 on 5/3/2018, 1,182 on 5/3/2019 and 1,218 on 5/3/2020. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
F4: These shares include 1,086 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
F5: These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/3/2018, 5/3/2019 and 5/3/2020, respectively.
Catalent, Inc.
Report date October 27, 2023 · Filed October 31, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 27,441 |
Reported balance
After 2023-10-27 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-10-27 · Grant · Acquired 6,993 · Balance 27,441 F1: The equity acquired by the reporting person is the annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-employee director compensation program. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur one year from the date of award, subject to continued service. F2: Includes restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: The equity acquired by the reporting person is the annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-employee director compensation program. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur one year from the date of award, subject to continued service.
F2: Includes restricted stock units.
Replimune Group, Inc.
Report date April 01, 2026 · Filed April 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.61 · Expires 2036-04-01 | Direct | 44,500 |
Reported balance
After 2026-04-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-04-01 · Grant · Acquired 44,500 · Balance 44,500 F1: The shares underlying this option vest entirely on April 1, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares underlying this option vest entirely on April 1, 2027.
Stevanato Group S.p.A.
Report date June 12, 2026 · Filed June 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 69,458 |
Ending reported balance
After 2026-06-15 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-06-12 · Grant · Acquired 4,975 · Balance 70,951 F1: Represents ordinary shares granted as equity compensation in connection with the Reporting Person's service as director. Row 2 · 2026-06-15 · Sale · Disposed 1,493 · Balance 69,458 F2: Represents ordinary shares sold by the Reporting Person to cover tax obligations associated with the grant of ordinary shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents ordinary shares granted as equity compensation in connection with the Reporting Person's service as director.
F2: Represents ordinary shares sold by the Reporting Person to cover tax obligations associated with the grant of ordinary shares.
uniQure N.V.
Report date June 17, 2026 · Filed June 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 43,254 |
Ending reported balance
After 2026-06-17 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2026-06-17 · Exercise / conversion · Acquired 5,295 · Balance 48,549 F1: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on March 10, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Row 2 · 2026-06-17 · Exercise / conversion · Acquired 6,390 · Balance 54,939 F1: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on March 10, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Row 3 · 2026-06-17 · Sale · Disposed 5,295 · Balance 49,644 F1: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on March 10, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.00 to $47.36. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. Row 4 · 2026-06-17 · Sale · Disposed 4,700 · Balance 44,944 F1: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on March 10, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.12 to $43.95. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. Row 5 · 2026-06-17 · Sale · Disposed 1,690 · Balance 43,254 F1: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on March 10, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.50 to $42.93. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $31.71 · Expires 2029-01-25 | Direct | 0 |
Reported balance
After 2026-06-17 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-06-17 · Exercise / conversion · Disposed 5,295 · Balance 0 F1: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on March 10, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F5: The Stock Option vested in full on January 25, 2020. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $19.39 · Expires 2028-01-26 | Direct | 0 |
Reported balance
After 2026-06-17 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-06-17 · Exercise / conversion · Disposed 6,390 · Balance 0 F1: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on March 10, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F6: The Stock Option vested in full on January 26, 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on March 10, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.00 to $47.36. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.
F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.12 to $43.95. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.
F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.50 to $42.93. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.
F5: The Stock Option vested in full on January 25, 2020.
F6: The Stock Option vested in full on January 26, 2019.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 17, 2026 Filed Jun 22, 2026 12:05 UTC | uniQure N.V. QURE · Entity 4162 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,390 | $0.00 Strike: $19.39 | $0.00 |
DisclosureSEC source: 0000904454-26-000370 · edgar.xml · derivative · entry 7 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,390 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on March 10, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F6 · derivative.exercise_date: The Stock Option vested in full on January 26, 2019. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 12:05 UTC | uniQure N.V. QURE · Entity 4162 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,295 | $0.00 Strike: $31.71 | $0.00 |
DisclosureSEC source: 0000904454-26-000370 · edgar.xml · derivative · entry 6 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 5,295 shares Expires 2029-01-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on March 10, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F5 · derivative.exercise_date: The Stock Option vested in full on January 25, 2020. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 12:05 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 1,690 | $42.60 | $71,994.00 |
DisclosureSEC source: 0000904454-26-000370 · edgar.xml · nonDerivative · entry 5 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,254 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on March 10, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.50 to $42.93. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 12:05 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 4,700 | $43.66 | $205,202.00 |
DisclosureSEC source: 0000904454-26-000370 · edgar.xml · nonDerivative · entry 4 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,944 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on March 10, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.12 to $43.95. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 12:05 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 5,295 | $47.08 | $249,288.60 |
DisclosureSEC source: 0000904454-26-000370 · edgar.xml · nonDerivative · entry 3 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,644 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on March 10, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.00 to $47.36. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 12:05 UTC | uniQure N.V. QURE · Entity 4162 | Exercise / conversionOrdinary Shares | 6,390 | $19.39 | $123,902.10 |
DisclosureSEC source: 0000904454-26-000370 · edgar.xml · nonDerivative · entry 2 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,939 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on March 10, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 12:05 UTC | uniQure N.V. QURE · Entity 4162 | Exercise / conversionOrdinary Shares | 5,295 | $31.71 | $167,904.45 |
DisclosureSEC source: 0000904454-26-000370 · edgar.xml · nonDerivative · entry 1 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,549 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on March 10, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 21:02 UTC | uniQure N.V. QURE · Entity 4162 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $8.49 | $0.00 |
DisclosureSEC source: 0000904454-26-000366 · edgar.xml · derivative · entry 3 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 10,000 shares Expires 2027-09-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on March 10, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · derivative.exercise_date: The Stock Option vested in full on September 20, 2021. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 21:02 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 10,000 | $27.85 | $278,500.00 |
DisclosureSEC source: 0000904454-26-000366 · edgar.xml · nonDerivative · entry 2 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,254 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on March 10, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.58 to $28.05. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 21:02 UTC | uniQure N.V. QURE · Entity 4162 | Exercise / conversionOrdinary Shares | 10,000 | $8.49 | $84,900.00 |
DisclosureSEC source: 0000904454-26-000366 · edgar.xml · nonDerivative · entry 1 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,254 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on March 10, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 15, 2026 Filed Jun 26, 2026 10:18 UTC | Stevanato Group S.p.A. STVN · Entity 3826 | SaleOrdinary Shares | 1,493 | $17.09 | $25,515.37 |
DisclosureSEC source: 0001193125-26-283819 · ownership.xml · nonDerivative · entry 2 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,458 F2 · shares: Represents ordinary shares sold by the Reporting Person to cover tax obligations associated with the grant of ordinary shares. Read SEC document |
| June 12, 2026 Filed Jun 26, 2026 10:18 UTC | Stevanato Group S.p.A. STVN · Entity 3826 | GrantOrdinary Shares | 4,975 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-283819 · ownership.xml · nonDerivative · entry 1 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,951 F1 · shares: Represents ordinary shares granted as equity compensation in connection with the Reporting Person's service as director. Read SEC document |
| June 11, 2026 Filed Jun 12, 2026 21:08 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 1,993 | $27.06 | $53,930.58 |
DisclosureSEC source: 0000904454-26-000337 · edgar.xml · nonDerivative · entry 2 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,254 F2 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F2 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.92 to $27.25. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 21:08 UTC | uniQure N.V. QURE · Entity 4162 | GrantStock Option (Right to Buy) · Derivative | 13,980 | $0.00 Strike: $26.82 | $0.00 |
DisclosureSEC source: 0000904454-26-000337 · edgar.xml · derivative · entry 3 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,980 Underlying: Ordinary Shares · 13,980 shares Expires 2036-06-10 F4 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 21:08 UTC | uniQure N.V. QURE · Entity 4162 | GrantOrdinary Shares | 7,550 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-26-000337 · edgar.xml · nonDerivative · entry 1 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,247 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| April 01, 2026 Filed Apr 8, 2026 01:09 UTC | Replimune Group, Inc. REPL · Entity 4707 | GrantStock Option (right to buy) · Derivative | 44,500 | $0.00 Strike: $7.61 | $0.00 |
DisclosureSEC source: 0001104659-26-040573 · tm2611350-12_4seq1.xml · derivative · entry 1 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,500 Underlying: Common Stock · 44,500 shares Expires 2036-04-01 F1 · derivative.exercise_date: The shares underlying this option vest entirely on April 1, 2027. Read SEC document |
| June 20, 2025 Filed Jun 24, 2025 21:42 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 2,112 | $14.45 | $30,518.40 |
DisclosureSEC source: 0000904454-25-000330 · edgar.xml · nonDerivative · entry 1 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,697 F1 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F1 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.40 to $14.50. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 20:44 UTC | uniQure N.V. QURE · Entity 4162 | GrantStock Option (Right to Buy) · Derivative | 15,630 | $0.00 Strike: $16.22 | $0.00 |
DisclosureSEC source: 0000904454-25-000309 · edgar.xml · derivative · entry 2 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,630 Underlying: Ordinary Shares · 15,630 shares Expires 2035-06-11 F2 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 20:44 UTC | uniQure N.V. QURE · Entity 4162 | GrantOrdinary Shares | 7,970 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-25-000309 · edgar.xml · nonDerivative · entry 1 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,809 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| April 01, 2025 Filed Apr 4, 2025 00:05 UTC | Replimune Group, Inc. REPL · Entity 4707 | GrantStock Option (right to buy) · Derivative | 32,000 | $0.00 Strike: $8.40 | $0.00 |
DisclosureSEC source: 0001104659-25-031833 · tm2511407-9_4seq1.xml · derivative · entry 1 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2035-04-01 F1 · derivative.exercise_date: The shares underlying this option vest entirely on April 1, 2026. Read SEC document |
| September 04, 2024 Filed Sep 6, 2024 00:10 UTC | Replimune Group, Inc. REPL · Entity 4707 | GrantEmployee Stock Option (right to buy) · Derivative | 64,000 | $0.00 Strike: $10.44 | $0.00 |
DisclosureSEC source: 0001104659-24-097495 · tm2423447-2_4seq1.xml · derivative · entry 1 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,000 Underlying: Common Stock · 64,000 shares Expires 2034-09-04 F1 · derivative.exercise_date: 25% of the shares underlying this stock option vest on September 4, 2025, and the remainder of the shares underlying this stock option vest in 24 approximately equal monthly installments thereafter. Read SEC document |
| June 19, 2024 Filed Jun 21, 2024 21:07 UTC | uniQure N.V. QURE · Entity 4162 | GrantStock Option (Right to Buy) · Derivative | 15,840 | $0.00 Strike: $4.57 | $0.00 |
DisclosureSEC source: 0000904454-24-000401 · edgar.xml · derivative · entry 2 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,840 Underlying: Ordinary Shares · 15,840 shares Expires 2034-06-19 F2 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| June 19, 2024 Filed Jun 21, 2024 21:07 UTC | uniQure N.V. QURE · Entity 4162 | GrantOrdinary Shares | 8,080 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-24-000401 · edgar.xml · nonDerivative · entry 1 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,839 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| June 13, 2024 Filed Jun 17, 2024 23:30 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 2,231 | $5.12 | $11,422.72 |
DisclosureSEC source: 0000904454-24-000371 · edgar.xml · nonDerivative · entry 1 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,759 F1 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F1 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.12 to $5.15. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 27, 2023 Filed Oct 31, 2023 21:07 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 6,993 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-23-000163 · wk-form4_1698786450.xml · nonDerivative · entry 1 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,441 F1 · shares: The equity acquired by the reporting person is the annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-employee director compensation program. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur one year from the date of award, subject to continued service. F2 · balance_after: Includes restricted stock units. Read SEC document |
| June 16, 2023 Filed Jun 20, 2023 21:17 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 2,283 | $18.91 | $43,171.53 |
DisclosureSEC source: 0000904454-23-000392 · edgar.xml · nonDerivative · entry 2 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,990 F3 · kind: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units. F3 · shares: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.89 to $18.91. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 13, 2023 Filed Jun 20, 2023 21:17 UTC | uniQure N.V. QURE · Entity 4162 | GrantStock Option (Right to Buy) · Derivative | 17,060 | $0.00 Strike: $20.18 | $0.00 |
DisclosureSEC source: 0000904454-23-000392 · edgar.xml · derivative · entry 3 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,060 Underlying: Ordinary Shares · 17,060 shares Expires 2033-06-13 F2 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| June 13, 2023 Filed Jun 20, 2023 21:17 UTC | uniQure N.V. QURE · Entity 4162 | GrantOrdinary Shares | 8,700 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-23-000392 · edgar.xml · nonDerivative · entry 1 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,273 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:17 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 384 | $19.99 | $7,676.16 |
DisclosureSEC source: 0000899243-23-006590 · doc4.xml · nonDerivative · entry 1 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,573 F1 · kind: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units. F1 · shares: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units. Read SEC document |
| October 27, 2022 Filed Oct 31, 2022 20:34 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 4,149 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-22-000159 · wf-form4_166724848023156.xml · nonDerivative · entry 1 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,448 F1 · kind: The equity acquired by the reporting person is the regular, annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-employee director compensation package. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur on the earlier of one year from the date of award and the date of the Issuer's fiscal 2023 annual meeting of shareholders. F2 · balance_after: Includes restricted stock units. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 20:27 UTC | uniQure N.V. QURE · Entity 4162 | GrantStock Option (Right to Buy) · Derivative | 17,810 | $0.00 Strike: $14.08 | $0.00 |
DisclosureSEC source: 0000904454-22-000354 · edgar.xml · derivative · entry 2 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,810 Underlying: Ordinary Shares · 17,810 shares Expires 2032-06-15 F2 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 20:27 UTC | uniQure N.V. QURE · Entity 4162 | GrantOrdinary Shares | 9,080 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-22-000354 · edgar.xml · nonDerivative · entry 1 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,957 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 22:30 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 602 | $16.70 | $10,053.40 |
DisclosureSEC source: 0000904454-22-000213 · edgar.xml · nonDerivative · entry 1 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,877 F1 · kind: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units. F1 · shares: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.70 to $16.81. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 23:19 UTC | uniQure N.V. QURE · Entity 4162 | GrantStock Option (Right to Buy) · Derivative | 2,645 | $0.00 Strike: $16.04 | $0.00 |
DisclosureSEC source: 0000904454-22-000191 · edgar.xml · derivative · entry 2 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,645 Underlying: Ordinary Shares · 2,645 shares Expires 2032-02-24 F2 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 23:19 UTC | uniQure N.V. QURE · Entity 4162 | GrantOrdinary Shares | 1,534 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-22-000191 · edgar.xml · nonDerivative · entry 1 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,479 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| October 28, 2021 Filed Nov 1, 2021 11:59 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 1,402 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-21-000167 · wf-form4_163576793292843.xml · nonDerivative · entry 1 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,299 F1 · kind: The equity acquired by the reporting person is the regular, annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-management director compensation package. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur on the earlier of one year from the date of award and the date of the Issuer's fiscal 2022 annual meeting of shareholders. F2 · balance_after: Includes restricted stock units. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 19:10 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 505 | $37.50 | $18,937.50 |
DisclosureSEC source: 0000904454-21-000291 · edgar.xml · nonDerivative · entry 1 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,945 F1 · kind: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units. F1 · shares: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.76 to $37.35. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 21:18 UTC | uniQure N.V. QURE · Entity 4162 | GrantStock Option (Right to Buy) · Derivative | 4,107 | $0.00 Strike: $37.00 | $0.00 |
DisclosureSEC source: 0000904454-21-000259 · edgar.xml · derivative · entry 2 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,107 Underlying: Ordinary Shares · 4,107 shares Expires 2031-02-25 F2 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 21:18 UTC | uniQure N.V. QURE · Entity 4162 | GrantOrdinary Shares | 2,382 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-21-000259 · edgar.xml · nonDerivative · entry 1 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,450 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| October 29, 2020 Filed Nov 2, 2020 12:19 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 2,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-20-000209 · wf-form4_160431957903251.xml · nonDerivative · entry 1 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,897 F1 · kind: The equity acquired by the reporting person is the regular, annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-management director compensation package. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur on the earlier of one year from the date of award and the date of the Issuer's fiscal 2021 annual meeting of shareholders. F2 · balance_after: Includes restricted stock units. Read SEC document |
| August 27, 2020 Filed Aug 28, 2020 22:45 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 661 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-20-000139 · wf-form4_159865472529301.xml · nonDerivative · entry 1 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,772 F1 · kind: The equity acquired by the reporting person is part of the regular, annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-management director compensation package. The grant is in respect of the period between July 1, 2020 and the date of the reporting person's annual meeting of shareholders in respect of fiscal 2020. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur one year from the date of award. F2 · balance_after: Includes restricted stock units. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 20:52 UTC | uniQure N.V. QURE · Entity 4162 | GrantStock Option (Right to Buy) · Derivative | 3,620 | $0.00 Strike: $51.81 | $0.00 |
DisclosureSEC source: 0000904454-20-000261 · edgar.xml · derivative · entry 2 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,620 Underlying: Ordinary Shares · 3,620 shares Expires 2030-02-27 F2 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 20:52 UTC | uniQure N.V. QURE · Entity 4162 | GrantOrdinary Shares | 2,063 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-20-000261 · edgar.xml · nonDerivative · entry 1 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,068 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| January 28, 2020 Filed Jan 31, 2020 02:23 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 807 | $62.20 | $50,195.40 |
DisclosureSEC source: 0000904454-20-000118 · edgar.xml · nonDerivative · entry 1 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,005 F1 · kind: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units. F1 · shares: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units. Read SEC document |
| August 22, 2019 Filed Aug 26, 2019 19:45 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 3,167 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-19-000150 · wf-form4_156684869814370.xml · nonDerivative · entry 1 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,111 F1 · kind: The equity acquired by the reporting person is the regular, annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-management director compensation package. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur one year from the date of award. F2 · balance_after: Includes restricted stock units. Read SEC document |
| January 28, 2019 Filed Jan 30, 2019 22:32 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 1,210 | $31.31 | $37,885.10 |
DisclosureSEC source: 0000904454-19-000134 · edgar.xml · nonDerivative · entry 1 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,812 F1 · kind: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units. F1 · shares: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.26 to $31.36. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 25, 2019 Filed Jan 29, 2019 23:53 UTC | uniQure N.V. QURE · Entity 4162 | GrantStock Option (Right to Buy) · Derivative | 5,295 | $0.00 Strike: $31.71 | $0.00 |
DisclosureSEC source: 0000904454-19-000094 · edgar.xml · derivative · entry 2 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,295 Underlying: Ordinary Shares · 5,295 shares Expires 2029-01-25 F2 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| January 25, 2019 Filed Jan 29, 2019 23:53 UTC | uniQure N.V. QURE · Entity 4162 | GrantOrdinary Shares | 3,230 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-19-000094 · edgar.xml · nonDerivative · entry 1 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,022 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| August 23, 2018 Filed Aug 24, 2018 18:46 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 4,183 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-18-000064 · wf-form4_153513636564472.xml · nonDerivative · entry 1 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,944 F1 · kind: The equity acquired by the reporting person is the regular, annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-management director compensation program. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur one year from the date of award. F2 · balance_after: Includes restricted stock units. Read SEC document |
| January 26, 2018 Filed Jan 30, 2018 16:20 UTC | uniQure N.V. QURE · Entity 4162 | GrantStock Option (Right to Buy) · Derivative | 6,390 | $0.00 Strike: $19.39 | $0.00 |
DisclosureSEC source: 0000904454-18-000066 · edgar.xml · derivative · entry 2 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,390 Underlying: Ordinary Shares · 6,390 shares Expires 2028-01-26 F2 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.